Advertisement

Direct oral anticoagulants for the treatment of cerebral vein thrombosis

Published:November 05, 2022DOI:https://doi.org/10.1016/j.thromres.2022.11.001

      Highlights

      • Direct oral anticoagulants as alternative treatment for cerebral vein thrombosis
      • No significant difference has been observed for the risk of recurrent thrombosis
      • The risk of bleeding was higher on direct oral anticoagulants than on warfarin

      Abbreviations:

      CVT (cerebral vein thrombosis), VKA (vitamin K antagonist), DOAC (direct oral anticoagulant), IR (incidence rate), HR (hazard ratio), CI (confidence interval), Pt-yr (patient-years)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Coutinho J.M.
        • Zuurbier S.M.
        • Aramideh M.
        • Stam J.
        The incidence of cerebral venous thrombosis: a cross-sectional study.
        Stroke. 2012; 43: 3375-3377
        • Capecchi M.
        • Abbattista M.
        • Martinelli I.
        Cerebral venous sinus thrombosis.
        J. Thromb. Haemost. 2018; 16: 1918
        • Dentali F.
        • Crowther M.
        • Ageno W.
        Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis.
        Blood. 2006; 107: 2766-2773
        • Bousser M.-G.
        • Crassard I.
        Cerebral venous thrombosis, pregnancy and oral contraceptives.
        Thromb. Res. 2012; 130: S19-S22
        • Ferro J.M.
        • Bousser M.-G.
        • Canhão P.
        • Coutinho J.M.
        • Crassard I.
        • Dentali F.
        • Minno M.
        • Maino A.
        • Martinelli I.
        • Masuhr F.
        • Aguiar de Sousa D.
        • Stam J.
        European stroke organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology.
        Eur. J. Neurol. 2017; 24: 1203-1213
        • Martinelli I.
        • De Stefano V.
        • Mannucci P.M.
        Inherited risk factors for venous thromboembolism.
        Nat. Rev. Cardiol. 2014; 11: 140-156
        • Martinelli I.
        • Abbattista M.
        • Bucciarelli P.
        • Tripodi A.
        • Artoni A.
        • Gianniello F.
        • Novembrino C.
        • Peyvandi F.
        Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban.
        Haematologica. 2018; 103: e315-e317
        • Pengo V.
        • Denas G.
        • Zoppellaro G.
        • Jose S.P.
        • Hoxha A.
        • Ruffatti A.
        • Andreoli L.
        • Tincani A.
        • Cenci C.
        • Prisco D.
        • Fierro T.
        • Gresele P.
        • Cafolla A.
        • De Micheli V.
        • Ghirarduzzi A.
        • Tosetto A.
        • Falanga A.
        • Martinelli I.
        • Testa S.
        • Barcellona D.
        • et al.
        Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.
        Blood. 2018; 132: 1365-1371
        • Nepal G.
        • Kharel S.
        • Bhagat R.
        • Ka Shing Y.
        • Ariel Coghlan M.
        • Poudyal P.
        • Ojha R.
        • Sunder Shrestha G.
        Safety and efficacy of direct oral anticoagulants in cerebral venous thrombosis: a meta-analysis.
        Acta Neurol. Scand. 2022; 145: 10-23
        • Samuelson Bannow B.T.
        • Chi V.
        • Sochacki P.
        • McCarty O.J.T.
        • Baldwin M.K.
        • Edelman A.B.
        Heavy menstrual bleeding in women on oral anticoagulants.
        Thromb. Res. 2021; 197: 114-119